SRPT


Goldman Sachs: These 3 Stocks Are Poised to Soar by at Least 30%

Once again, stocks have delivered an upset. Despite the havoc wreaked by COVID-19 during the second quarter, corporate profits have generally been better-than-expected.

Sarepta, Codiak BioSciences Team Up For Neuromuscular Disease Targeting

Sarepta Therapeutics (SRPT) has announced that it has teamed up with Codiak BioSciences to design and develop engineered exosome therapeutics to deliver gene therapy, …

Sarepta Reports Earnings Miss; But Key SRP-9001 Data Still On Track

Sarepta Therapeutics (SRPT) has reported weaker-than-expected earning results for the first quarter. Specifically, Q1 Non-GAAP EPS of -$1.

BTIG: New Data Could Propel These 3 Biotech Stocks Higher in 2020

For those who like patterns, biotech names’ growth stories tend to look remarkably similar. These stocks are less reliant on earnings reports and …

This Looks Like Just the Beginning for Sarepta Therapeutics (SRPT) Stock

There’s a new FDA-approved DMD medication on the scene. On Friday, the FDA green-lighted Sarepta Therapeutics’ (SRPT) Vyondys 53, the company’s treatment for …

Why Did Farallon Capital Get Out of These 3 Biotech Stocks?

Since 1986, Farallon Capital has built a proven record for success, mainly from steady hands at the helm and consistent returns for investors. …

3 Stocks That Wall Street Thinks Could Rise 40% or More

After a period of uncertainty, confidence has returned to the market and sent stock prices soaring. This begs the question, have stocks soared …

Sarepta (SRPT) Stock Still Worth Over $200, Says Top Analyst

On Monday, when the FDA came out against Sarepta Therapeutics’ (SRPT) Duchenne muscular dystrophy drug Vyondys 53, investors knew the shockwaves would immediately …

Are These 5 Biotech Stocks About to Get Bought Out?

In a previous article, I talked about the so-called patent cliff and the correlation to the pace of mergers and acquisitions in the pharma …

Top Analyst Says Sarepta (SRPT) Stock Has More Room to Run

Christmas is over and it seems like people spent their gift money on stocks… Sarepta Therapeutics (SRPT) stock rose over 10% is the …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts